Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium.

Eva AltrockCarla Sens-AlbertFranziska HofmannVladimir RiabovNanni SchmittQingyu XuJohann-Christoph JannFelicitas RappLaurenz SteinerAlexander StreuerVerena NowakJulia ObländerNadine WeimerIris PalmeMelda GölAli DarwichPatrick WuchterGeorgia MetzgerothMohamad JawharWolf-Karsten HofmannDaniel Nowak

Published in: Stem cell research & therapy (2023)

Our data indicate that with XF media, higher cell numbers of MDS MSCs can be obtained with overall improved characteristics in in vitro and in vivo experimental models.

Keyphrases

end stage renal disease
mesenchymal stem cells
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
single cell
stem cells
bone marrow
patient reported outcomes
artificial intelligence
umbilical cord